z-logo
open-access-imgOpen Access
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells
Author(s) -
Ursula Thiem,
Tim D. Hewitson,
Nigel D. Toussaint,
S. Holt,
Maria Haller,
Andreas Pasch,
Daniel Cejka,
Edward R. Smith
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac271
Subject(s) - medicine , inflammation , endogeny , hemodialysis , dialysis , phosphate , phosphate binder , kidney disease , hyperphosphatemia , biochemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom